About
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Through our core commitments, we are leveraging our scale for the greater good, such as serving the needs of our stakeholders, donating back to our communities, protecting our planet, working with policymakers, and more.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportOur businesses bring together leading technologies, innovative solutions and hands-on expertise to support the entire healthcare ecosystem.
We distribute pharmaceuticals and medical supplies to healthcare settings across North America, from pharmacies and hospitals to doctors’ offices and clinics.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
We provide research, insights, technologies and other support to help address challenges in cancer and specialty care.
We provide a suite of solutions designed to address access, affordability and adherence challenges by bridging the gaps between biopharma companies, pharmacies, providers, and payers to help patients get on and stay on their medications.
We offer solutions that enable employers, payers, health-plan brokers and government agencies to provide lower-cost options for prescription medications and therapies.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportMcKesson supports healthcare providers and partners to improve access, strengthen local care, and help ensure medications reach patients in communities nationwide.
Read Time
2 minutes
Key Points:
Millions of patients in the U.S. face barriers to receiving essential care, from advanced treatments and critical medications to participation in clinical trials, driven by factors ranging from affordability to geography.
At McKesson, we’re improving patient care by powering healthcare locally and solving access and affordability challenges. We make healthcare happen by supporting providers who deliver cancer and specialty care, connecting patients to advanced treatment options and clinical trials, and helping ensure care is available in communities across the country. Our role is to support, never replace, independent clinical judgment so care decisions remain between physicians and their patients.
We partner behind the scenes with those who are on the front line of care so that our customers can stay focused on what matters most: their patients. Our digitally connected distribution network ensures medications reach every healthcare setting, from neighborhood pharmacies to community hospitals to local providers, whether in major cities or rural areas.
McKesson’s GPOs empower independent healthcare providers to access differentiated contract pricing and terms, navigate rising drug costs and sustain community-based care.
Leveraging data from the largest community oncology networks, we look at factors increasing colorectal cancer in younger patients.
How treatment centers can access CGTs through two different channel strategies — Buy-and-Bill and Specialty Pharmacy.
Discover how coordinated rare disease care simplifies complex workflows, supports providers with specialty pharmacy services, and improves the patient journey.
Discover how InspiroGene by McKesson is collaborating with Biologics by McKesson to streamline cell and gene therapy delivery and accelerate patient access to treatments.
The efforts and innovations enabling local cancer care practices to provide advanced, personalized therapies close to patients’ homes
McKesson Amplify enters its second year providing dedicated funding to state pharmacy associations to strengthen independent pharmacies and advance advocacy.
Learn how we help accelerate innovative therapy launches so providers can access them when and where patients need them most.
Biopharma and community oncology must unite in a new patient reality.